Woodline Partners LP Cytokinetics Inc Transaction History
Woodline Partners LP
- $14.3 Billion
- Q1 2025
A detailed history of Woodline Partners LP transactions in Cytokinetics Inc stock. As of the latest transaction made, Woodline Partners LP holds 212,303 shares of CYTK stock, worth $6.79 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
212,303
Previous 126,201
68.23%
Holding current value
$6.79 Million
Previous $5.94 Million
43.73%
% of portfolio
0.06%
Previous 0.04%
Shares
5 transactions
Others Institutions Holding CYTK
# of Institutions
408Shares Held
127MCall Options Held
3.66MPut Options Held
900K-
Black Rock Inc. New York, NY14.7MShares$470 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$379 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.96MShares$319 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA7.99MShares$256 Million0.06% of portfolio
-
State Street Corp Boston, MA6.09MShares$195 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.01B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...